処理中

しばらくお待ちください...

WIPO - PCT Applicant's Guide US - アメリカ合衆国
米国特許商標庁(USPTO)

    有益情報

    PCT出願人の手引は、国際事務局が受理した情報に基づきほぼ毎週更新される。
    質問は、当該官庁又は国際事務局へ問い合わせされたい: pct.guide@wipo.int.
    略語のリスト
    Office: United States Patent and Trademark Office (USPTO)
    35 USC: Title 35, United States Code, Patents
    The number cited after the letters USC or CFR is the relevant section of the Patent Statute or of the Regulations, respectively
    37 CFR: Title 37, Code of Federal Regulations, Patents, Trademarks and Copyrights
    The number cited after the letters USC or CFR is the relevant section of the Patent Statute or of the Regulations, respectively
    AIA: Leahy-Smith America Invents Act
    通貨のリスト
    CHF (スイス・フラン), EUR (ユーロ), NZD (ニュージーランド・ドル), USD (米国・ドル), ZAR (南アフリカ・ランド)
    国及び官庁に関する情報
    官庁の略称リストは、WIPO標準ST.3が提供する各2文字コードのマウスオーバー機能に統合されたため表示されない。WIPO標準、推奨、ガイドラインのリスト(旧附属書K、国名及び2文字コードリスト)を参照のこと。当リストには、PCTに基づく国際出願の関連書類において、国家、その他の組織及び政府間機関を表示するために使用が認められている短縮名称及び2文字コードが記載される。当リストはWIPO標準ST.3に規定される。PCT締約国の一覧表(旧附属書A)も併せて参照のこと。
    官庁プロファイル
    国内官庁の詳細な情報は、ePCTの官庁プロファイルを参照のこと.
    PCT留保、申立て、通知及び不適合
    第64条(3)(a),
    第64条(4)(a),
    規則20.1(d),
    規則23の2.2(e),
    規則26.3の3(b),
    規則26.3の3(d),
    規則49.5(l) (規則49.5(cの2)に関する),
    規則49.5(l) (規則49.5(k)に関する),

    一覧表を参照のこと
    官庁の閉庁日
    国内官庁は、毎週土曜日、日曜日に閉庁
    追加の閉庁日に関しては、官庁の閉庁日のページを参照

    国際段階

    附属書B - 一般情報

    締約国
    アメリカ合衆国
    2文字コード
    US
    国内官庁の名称
    米国特許商標庁(USPTO)
    所在地
    Customer Service Window
    Randolph Building
    401 Dulany Street
    Alexandria
    VA 22314
    United States of America
    (first floor of the south side of the Randolph Building with street level access from Ballenger Avenue)
    郵便のあて名
    Mail Stop PCT
    Commissioner for Patents
    P.O. Box 1450
    Alexandria
    Virginia 22313-1450
    United States of America
    電話番号
    PCT ヘルプデスク
    (1-571) 272 43 00
    Toll free technical support for electronic filing
    (1-866) 217 91 97
    Local technical support for electronic filing
    (1-571) 272-41 00
    電子メール
    PCTHelp@uspto.gov
    As from 1 January 2022, for one year on a pilot basis, for submitting general and non time sensitive questions regarding the PCT and the procedures applicable to international applications filed under the PCT and U.S. national phase applications submitted under 35 U.S.C. §371. This pilot has been extended for an additional year as from 1 January 2023. It should be noted that this e-mail address is not intended for case specific or time sensitive inquiries, which should still be directed by telephone to the PCT Help Desk ((1-571) 272 43 00)
    ファクシミリ
    For details of which documents may be sent by facsimile refer to “Does the Office accept the filing of documents by facsimile or the like means (PCT Rule 92.4)?”
    PCT Operations – only available for certain documents
    (1-571) 273 83 00
    USPTO Central Fax – only available for certain documents
    (1-571) 273 83 00
    PCT ヘルプデスク
    (1-571) 273 04 19
    ファクシミリ又は同様の手段による書類の提出を受理するか(PCT規則92.4)?
    ファクシミリによる提出を受理する
    送付することができる書類の種類
    All documents except the following:
    — certified documents including priority documents
    — documents needed to receive an international filing date under PCT Article 11
    — authorizations charging the basic national fee to a deposit account
    — when necessary, a copy of the international application for entry into the national phase
    — documents directly related to a secrecy order
    書類の原本提出義務
    請求がない限り提出義務はない
    国際出願に関する通知を電子メールで送付するか?
    されない
    郵政当局以外の配達サービスを利用した場合に亡失又は遅延があったとき書類を発送したことの証拠を受理するか?(PCT規則82.1)
    されない
    出願人がWIPO優先権書類デジタルアクセスサービス(DAS)に出願を利用可能とすることを許可する用意があるか?(PCT規則17.1(bの2))
    出願人に電子形式で行われた国内出願をWIPO DASで利用可能とすることを許可する用意がある
    For further details on how to request this Office to make applications available to the DAS refer to:
    http://www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx
    However, the applicant may not request the receiving Office of the United States of America (RO/US) to obtain a priority document from a digital library and transmit it to the International Bureau pursuant to PCT Rule 17.1(b-bis)
    当該国の国民又は居住者による国際出願のための管轄受理官庁
    出願人は,国家安全保障の規定が外国出願を許容している場合に限り国際事務局に出願することができる。この規定に従うことは出願人の責任であり,国際事務局により検査はされない。
    IB,
    US
    国内法令は、外国官庁への国際出願を制限しているか?
    Title 35, United States Code, Patents, Sections 181 and 184-188. Also refer to 37 CFR 5.11-5.20
    次の場合、出願は制限される:
    Inventions made in the United States of America
    当該国の管轄指定 (又は選択) 官庁
    国内段階参照
    US
    PCTに基づき取得可能な保護の種類
    特許
    国際型調査に関する国内法令の規定(PCT第15条)
    Sections 1.104(a)(3) and (a)(4) and 1.21(e) of the Code of Federal Regulations, Title 37 (37 CFR)
    The USPTO does not require that a formal report of an international-type search be prepared in order to obtain a search fee refund in a later filed international application
    国際公開に基づく仮保護
    The patentee is entitled to obtain a reasonable royalty commencing on the date of the publication under PCT Article 21(2)(a) of the international application, or if the publication is in a language other than English, on the date the USPTO receives a translation of the international application in the English language. The right to obtain a reasonable royalty is not available unless the invention as claimed in the patent is substantially identical to the invention claimed in the published international application. For details, refer to National Chapter(US), paragraph US.47 (also refer to 35 USC 154(d)).
    国内官庁が指定 (又は選択) されている場合の有益情報
    [MT] 注意
    国際出願に基づき発行された米国特許において開示されている対象事項の「先行技術としての効果」
    The United States of America made a declaration under PCT Article 64(4). However, this declaration only applies to applications that are not subject to the First Inventor to File provisions of the America Invents Act, that is, applications that contain or ever contained a claim having an effective filing date prior to 16 March 2013
    Additional information regarding the applicability of the First Inventor to File provisions of the America Invents Act can be found at:
    http://www.uspto.gov/patents/first-inventor-file-fitf-resources
    発明者の氏名(名称)及びあて名を提示しなければならない時期
    May be in the request or may be furnished later. If the data concerning the inventor is missing at the expiration of the time limit under PCT Article 22 or 39(1), the Office will invite the applicant to comply with the requirement within a time limit fixed in the invitation.
    微生物及びその他の生物材料の寄託に関する特別の規定が設けられているか?
    あ り (附属書L参照)

    附属書C - 受理官庁

    右の国の国民及び居住者の管轄受理官庁
    アメリカ合衆国
    国際出願の作成に用いることができる言語
    英語
    配列表における言語依存フリーテキストのために認められる言語
    The Office does not permit the language-dependent free text of the sequence listing part of the description to be filed in more than one language, under PCT Rule 12.1(d).
    上記と同様
    願書の提出に用いることができる言語
    英語
    [MT] 紙面申請の場合受理局が必要とするコピー数:
    1
    受理官庁は電子形式による国際出願を認めるか?
    要求される
    Where the international application is filed in electronic form, the total amount of the international filing fee is reduced (refer to “Fees payable to the RO”).
    Where the international application contains a sequence listing as a separate part of the description, this should be furnished in accordance with Annex C of the Administrative Instructions, that is, in compliance with WIPO Standard ST.26 XML format; no fees are due for sequence listings filed in this format. Where the international application is filed on paper, a sequence listing part of the description should be furnished in WIPO Standard ST.26 XML format on physical medium.
    The USPTO accepts the filing of international applications in electronic form according to its national law and technical systems (refer to Section 703(d) and 703(f)(ii) of the PCT Administrative Instructions). For more information, refer to:
    https://www.uspto.gov/patents/apply
    Technical support for filing international applications electronically is available from the Patent Electronic Business Center (EBC) at (1-866) 217 91 97. Note that the applicable national law and technical systems provide for requirements which are different from, and not compatible with, the requirements of Section 703(b)(ii) to (iv) of the PCT Administrative Instructions (refer to PCT Gazette No. 18/2002, page 8974). Applicants may, however, use ePCT or PCT-SAFE to generate a .zip file containing a validated request form, and then submit the .zip file electronically via EFS-Web or Patent Center. For further details, refer to:
    https://www.federalregister.gov/documents/2020/09/30/2020-18743/facilitating-the-use-of-the-world-intellectual-property-organizations-epct-system-to-prepare
    受理官庁は優先権の回復請求を認めるか(PCT規則26の2.3)?
    認める。国内官庁は当該請求に「故意ではない」の基準を適用する。
    管轄国際調査機関
    AU, 1
    EP,
    IL, 2
    JP, 3
    KR,
    SG,
    US
    管轄国際予備審査機関
    AU, 4
    EP, 4
    IL, 4
    JP, 4
    KR,
    SG, 4
    US
    受理官庁に支払うべき手数料
    The amounts of these fees change periodically. The receiving Office or the current USPTO Fee Schedule should be consulted for the applicable amounts at:
    http://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
    送付手数料
    260 USD
    小企業 USD 104 5
    極小企業 USD 52 6
    [MT] さらに 次のようなものがあります
    [MT] 国際申請に対する非電子申請手数料
    400 USD
    —又は小企業若しくは極小企業の場合
    200 USD
    国際出願手数料
    1,454 USD
    この手数料は一定の条件が適用される場合に90%減額される(附属書C(IB)参照)。
    30枚を超える1枚ごとの手数料
    16 USD
    減額(手数料表第4項に基づく)
    [MT] 電子申請(EFS‐Web/特許センター無しePCTまたはPCT‐EASY.zipファイル):
    109 USD
    [MT] 電子申請(EFS‐Web/特許センターとePCTまたはPCT‐EASY.zipファイル):
    219 USD
    調査手数料
    Refer to
    Annex D(AU)
    Annex D(EP)
    Annex D(IL)
    Annex D(JP)
    Annex D(KR)
    Annex D(SG)
    Annex D(US)
    優先権書類の手数料(PCT規則17.1(b))
    なし
    優先権回復請求手数料(PCT規則26の2.3(d))
    2,100 USD
    小企業 USD 840 5
    極小企業 USD 420 6
    受理官庁は代理人を要求するか?
    されない
    誰が代理人として行為できるか?
    Patent attorneys and patent agents registered to practice before the Office. A list of registered patent attorneys and agents may be obtained on the Internet at:
    http://oedci.uspto.gov/OEDCI/
    委任状の提出要件の放棄
    Waivers of powers of attorney do not apply (PCT Rule 90.4(e) and 90.5(d)) where the agent or common representative submits any notice of withdrawal during the international phase (PCT Rule 90bis.1 to 90bis.4, also refer to International Phase, paragraph 11.048).
    受理官庁は,別個の委任状を提出する要件を放棄しているか?
    要求される
    別個の委任状が要求される特別の状況
    代理人と称する者が出願人を代理して行為をする権能を有して いるか明らかでない時、及びPCT規則92の2に基づく一定の変 更があった時
    受理官庁は,包括委任状の写しを提出する要件を放棄しているか?
    要求される
    包括委任状の写しが要求される特別の状況
    代理人と称する者が出願人を代理して行為をする権能を有して いるか明らかでない時、及びPCT規則92の2に基づく一定の変 更があった時

    附属書D - 国際調査機関

    次の受理官庁を管轄する国際調査機関
    BH,
    BR,
    CL,
    DO,
    EG,
    GE,
    IL,
    IN,
    JO,
    KN,
    MX,
    NZ,
    OM,
    PA,
    PE,
    PH,
    QA,
    SA,
    TH,
    TT,
    US,
    ZA
    国際調査機関に支払うべき手数料
    調査手数料(PCT規則16)
    1,994 CHF
    小企業 CHF 798 5
    極小企業 CHF 399 6
    2,070 EUR
    小企業 EUR 828 5
    極小企業 EUR 414 6
    3,652 NZD
    小企業 NZD 1,461 5
    極小企業 NZD 730 6
    2,180 USD
    小企業 USD 872 5
    極小企業 USD 436 6
    41,680 ZAR
    小企業 ZAR 16,670 5
    極小企業 ZAR 8,340 6
    This fee is payable to the receiving Office in the currency or one of the currencies accepted by it
    The amount of this fee changes periodically. The International Searching Authority or the current USPTO Fee Schedule should be consulted for the applicable amount at:
    http://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
    追加の調査手数料(PCT規則40.2)
    2,180 USD
    小企業 USD 872 5
    極小企業 USD 436 6
    The amount of this fee changes periodically. The International Searching Authority or the current USPTO Fee Schedule should be consulted for the applicable amount at:
    http://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
    This fee is payable to the International Searching Authority and only in particular circumstances
    国際調査報告に列記された文献の写しのための手数料(PCT規則44.3)
    米国特許文献
    米国特許書類 写し1通につき USD 3
    From 3 July 2007, the USPTO no longer mails paper copies of cited US patents and US patent application publications cited in search reports, written opinions or international preliminary examination reports in international applications
    From 29 October 2013, the USPTO also no longer mails copies of published international applications cited in international applications. However, electronic copies may be viewed at the USPTO’s Internet web site:
    http://www.uspto.gov/patents/search
    The copies can also be printed for free. Copies can also be purchased online:
    ebiz1.uspto.gov/oems25p/index.html
    or obtained from the USPTO Office of Public Records ((1-800) 972 63 82 or (571) 272 31 50) at the fee indicated above
    米国以外の特許文献
    なし
    The applicant receives, together with the international search report, a copy of each cited document that is not a US patent document or a published international application
    国際出願の一件書類中の文献の写しのための手数料(PCT規則94.1の3)
    米国特許文献
    米国特許書類 写し1通につき USD 3
    米国以外の特許文献
    写し1通につき USD 25
    Refer to 37 CFR 1.19 for other document supply fees
    異議申立手数料(PCT規則40.2(e))
    なし
    遅延提出手数料(PCT規則13の3.1(c))
    320 USD
    小企業 USD 128 5
    極小企業 USD 64 6
    調査手数料の払戻しの条件及び額
    過誤又は超過の料金は払い戻す
    国際調査の開始前にPCT第14条(1)、(3) 又は (4) の規定により国際出願が取下げられた又は取下げられたものとみなされた場合: 100%払戻し
    国際調査のために認める言語
    英語
    国際出願が,この国際調査機関が既に調査した先の出願から優先権を主張している場合,国際調査機関は先の調査結果に関する非公式コメントを受理するか?
    されない
    ヌクレオチド・アミノ酸の配列表の提出用に認められる物理的媒体の種類
    Read-only optical disc: CD–ROM, CD–R, DVD–R, DVD+R
    調査をしないこととしている対象
    The subject matter specified in items (i) to (vi) of PCT Rule 39.1 with the exception of any subject matter searched under the patent grant procedure in accordance with the provisions of United States patent law
    委任状の提出要件の放棄
    Waivers of powers of attorney do not apply (PCT Rule 90.4(e) and 90.5(d)) where the agent or common representative submits any notice of withdrawal during the international phase (PCT Rule 90bis.1 to 90bis.4, also refer to International Phase, paragraph 11.048).
    国際調査機関は,別個の委任状を提出する要件を放棄しているか?
    要求される
    別個の委任状が要求される特別の状況
    代理人と称する者が出願人を代理して行為をする権能を有して いるか明らかでない時、及びPCT規則92の2に基づく一定の変 更があった時
    国際調査機関は,包括委任状の写しを提出する要件を放棄しているか?
    要求される
    包括委任状の写しが要求される特別の状況
    代理人と称する者が出願人を代理して行為をする権能を有して いるか明らかでない時、及びPCT規則92の2に基づく一定の変 更があった時

    附属書E - 国際予備審査機関

    [MT] 米国特許庁が国際検索を行っている場合,または行っていた場合に限り,米国特許庁が国際予備審査機関として行動することができる。
    次の受理官庁について管轄する国際予備審査機関
    BH,
    BR,
    CL,
    DO,
    EG,
    GE,
    IL,
    IN,
    JO,
    KN,
    MX,
    NZ,
    OM,
    PA,
    PE,
    PH,
    QA,
    SA,
    TH,
    TT,
    US,
    ZA
    国際予備審査機関に支払うべき手数料
    予備審査手数料(PCT規則58)
    -国際調査がUSPTOにより行われた場合:
    640 USD
    小企業 USD 256 5
    極小企業 USD 128 6
    -国際調査がUSPTOにより行われなかった場合:
    800 USD
    小企業 USD 320 5
    極小企業 USD 160 6
    This fee is payable to the International Preliminary Examining Authority
    The amounts of these fees change periodically. The International Preliminary Examining Authority or the current USPTO Fee Schedule should be consulted for the applicable amounts at:
    http://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
    追加の予備審査手数料(PCT規則68.3)
    640 USD
    小企業 USD 256 5
    極小企業 USD 128 6
    This fee is payable to the International Preliminary Examining Authority and only in particular circumstances
    取扱手数料(PCT規則57.1)
    219 USD
    この手数料は国際予備審査機関に支払う。この手数料は一定の条件が適用される場合に90%減額される(附属書C(IB)参照)。
    国際予備審査報告に列記された文献の写しのための手数料(PCT規則71.2)
    なし
    The applicant receives, together with the international preliminary examination report, a copy of each additional document not cited in the international search report which is not a US patent document or a published international application
    From 3 July 2007, the USPTO no longer mails paper copies of cited US patents and US patent application publications cited in search reports, written opinions or international preliminary examination reports in international applications
    From 29 October 2013, the USPTO also no longer mails copies of published international applications cited in international applications. However, electronic copies may be viewed at the USPTO’s Internet web site:
    http://www.uspto.gov/patents/search
    The copies can also be printed for free. Copies can also be purchased online:
    ebiz1.uspto.gov/oems25p/index.html
    or obtained from the USPTO Office of Public Records ((1-800) 972 63 82 or (571) 272 31 50) at the fee indicated above
    国際出願の一件書類中の文書の写しのための手数料(PCT規則94.2)
    米国特許文献
    米国特許書類 写し1通につき USD 3
    米国以外の特許文献
    写し1通につき USD 25
    Refer to 37 CFR 1.19 for other document supply fees
    異議申立手数料(PCT規則68.3(e))
    なし
    遅延提出手数料(PCT規則13の3.2))
    320 USD
    小企業 USD 128 5
    極小企業 USD 64 6
    国際予備審査手数料の払戻しの条件及び額
    過誤又は超過の料金は払い戻す
    In the cases provided for under PCT Rule 58.3 where the demand is considered as if it had not been submitted (PCT Rules 54.4, 58bis.1(b) or 60.1(c)):
    refund of 100%
    If the international application or the demand is withdrawn before the start of the international preliminary examination:
    refund of the amount paid less a processing fee equivalent to the transmittal fee (refer to Annex C(US))
    国際予備審査のために認める言語
    英語
    審査をしないこととしている対象
    The subject matter specified in items (i) to (vi) of PCT Rule 67.1 with the exception of any subject matter examined under the patent grant procedure in accordance with the provisions of United States patent law
    委任状の提出要件の放棄
    Waivers of powers of attorney do not apply (PCT Rule 90.4(e) and 90.5(d)) where the agent or common representative submits any notice of withdrawal during the international phase (PCT Rule 90bis.1 to 90bis.4, also refer to International Phase, paragraph 11.048).
    国際調査機関は,別個の委任状を提出する要件を放棄しているか?
    要求される
    別個の委任状が要求される特別の状況
    代理人と称する者が出願人を代理して行為をする権能を有して いるか明らかでない時、及びPCT規則92の2に基づく一定の変 更があった時
    国際調査機関は,包括委任状の写しを提出する要件を放棄しているか?
    要求される
    包括委任状の写しが要求される特別の状況
    代理人と称する者が出願人を代理して行為をする権能を有して いるか明らかでない時、及びPCT規則92の2に基づく一定の変 更があった時

    附属書L 微生物及びその他の生物材料の寄託

    指定官庁及び選択官庁の要件
    適用される国内法令に,微生物及びその他の生物材料の寄託に関する規定が含まれている国内官庁だけがこの表に掲載されている。この表に別段の記載がない限り,これらの国内官庁に対する特許手続上,特許手続上の微生物の寄託の国際承認に関するブダペスト条約に基づく国際寄託当局の地位を取得しているすべての寄託機関に寄託を行うことができる。
    国際寄託当局のリストは、以下のリンクを参照。
    関連する通知は以下のリンクから確認できる。
    ブダペスト条約に基づく国際寄託当局の要件に関する詳しい情報は、以下のリンクに掲載されている。
    出願人が優先日から16か月より早い時期までに届け出なければならない事項(該当する場合)
    — 規則13の2.3(a)(ⅰ)から(ⅲ)に規定された事項
    なし
    — 追加事項
    出願時
    該当する国内官庁からの通知に基づき、規則13の2.3(a)(ⅰ)から(ⅲ)に規定された以外に届け出なければならない追加事項(該当する場合)
    To the extent feasible, a description of the deposited biological material sufficient to specifically identify it and to permit examination
    追加情報
    When the original deposit is made after the effective filing date of an application for a patent, the applicant must promptly submit a statement from a person in a position to corroborate the fact, stating that the biological material which is deposited is a biological material specifically identified in the application as filed (refer to 37 CFR 1.804(b)).
    Deposits may also be made for the purposes of patent procedure before the USPTO with any other depository institution recognized to be suitable by the Office (refer to 37 CFR 1.803).

    国内段階

    国内段階移行するための要件の概要

    国内段階移行するための期間
    PCT第22条(1)に基づく期間 :優先日から30箇月
    PCT第39条(1)(a)に基づく期間:優先日から30箇月
    要求される国際出願の翻訳文の言語
    Must be furnished within the time limit applicable under PCT Article 22 or 39(1). The requirement may still be complied with in response to a notice sent to the applicant, provided that a processing fee is paid for furnishing the translation later
    英語
    要求される翻訳文
    Must be furnished within the time limit applicable under PCT Article 22 or 39(1). The requirement may still be complied with in response to a notice sent to the applicant, provided that a processing fee is paid for furnishing the translation later
    If the translation of the amendments is not furnished, the amendments are considered to be cancelled (37 CFR 1.495(d) and (e))
    Under PCT Article 22: Request, description, claims (if amended, both as originally filed and as amended, together with any statement under PCT Article 19), any text matter in the drawings, abstract
    Under PCT Article 39(1): Request, description, claims, any text matter in the drawings, abstract (if any of those parts has been amended, both as originally filed and as amended by the annexes to the international preliminary report on patentability (Chapter II))
    特別な状況において国際出願の写しが要求されるか?
    PCT第22条若しくは第39条(1)に基づく期間内に提出しなければならない。
    国際出願の公開前に国内出願を行う場合にのみ,出願人は国際出願の写しを送付しなければならない。これは出願人がPCT第23条(2)に基づく国内段階の早期開始の明示の請求をした場合が考えられる。
    No copy is required if the international application was filed with the USPTO as receiving Office. A copy of amendments of the claims filed under PCT Article 19 with the International Bureau is required under the conditions indicated in the previous paragraph
    国内手数料
    The amounts of these fees change periodically. The United States Patent and Trademark Office or the current USPTO Fee Schedule should be consulted for the applicable amounts at:
    https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
    基本国内手数料
    320 USD
    小企業 (USD 128) 7
    極小企業 (USD 64) 8
    PCT第22条若しくは第39条(1)に基づく期間内に支払わなければならない。
    調査手数料
    国際予備審査機関(US)が特許性に関する国際予備報告(第Ⅱ章)を作成する,又は国際調査機関(US)が書面による見解を作成した場合であって,提出されたすべての請求の範囲がPCT第33条(1)から(4)までの規定を満たしている場合
    0 USD
    小企業(無料) 7
    極小企業(無料) 8
    [MT] ISAとしてUSPTOに支払われる国際検索料
    140 USD
    Small entity (56 USD) 7
    Micro entity (28 USD) 8
    国以外の国際調査機関が調査報告書を作成した場合であって,調査報告が提出される又は国際事務局から既にUSPTOに送達されている場合
    540 USD
    小企業 (USD 216) 7
    極小企業 (USD 108) 8
    その他の状況すべて
    700 USD
    小企業 (USD 280) 7
    極小企業 (USD 140) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    審査手数料
    国際予備審査機関(US)が特許性に関する国際予備報告(第Ⅱ章)を作成する,又は国際調査機関(US)が書面による見解を作成した場合であって,提出されたすべての請求の範囲がPCT第33条(1)から(4)までの規定を満たしている場合
    0 USD
    小企業(無料) 7
    極小企業(無料) 8
    その他の状況すべて
    800 USD
    小企業 (USD 320) 7
    極小企業 (USD 160) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    100枚を超える明細書及び図面,50枚又はその端数ごと(電子媒体で提出された配列リスト又はコンピュータプログラムを除く)
    420 USD
    小企業 (USD 168) 7
    極小企業 (USD 84) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    [MT] 独立形式の請求権が3件以上の場合は、それぞれ追加料金
    480 USD
    小企業 (USD 192) 7
    極小企業 (USD 96) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    [MT] 独立又は依存する請求権の数が20を超える場合
    100 USD
    小企業 (USD 40) 7
    極小企業 (USD 20) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    当該出願が1個以上の多数項引用形式の請求の範囲がある場合,1出願につき
    860 USD
    小企業 (USD 344) 7
    極小企業 (USD 172) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    国内段階手続の開始日後の,調査手数料若しくは審査手数料の支払,又は誓約書若しくは宣言書の提出のための割増料
    160 USD
    小企業 (USD 64) 7
    極小企業 (USD 32) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    [MT] PCT第22条又は第39条第1項に適用される期限を過ぎて申請した場合の処理費
    140 USD
    Small entity (56 USD) 7
    Micro entity (28 USD) 8
    基本国内手数料と併せて支払われていない場合、USPTOは通知に記載された期間内に出願人に調査手数料の支払を求める
    [MT] メガシーケンスリスト出願料:
    - 300MBから800MBまでの配列リスト提出
    1,060 USD
    小企業 (USD 424) 7
    極小企業 (USD 212) 8
    - 800MBを超える配列リスト提出
    10,500 USD
    小企業 (USD 4,200) 7
    極小企業 (USD 2,100) 8
    国内手数料の免除、減額又は払戻し
    Reductions of the national fees are indicated under the national fees listed above
    国内官庁の特別の要件(PCT規則51の2)
    発明者の宣誓書又は宣言書 9
    Information disclosure statement is recommended 10
    該当すれば、電子形式によるヌクレオチド・アミノ酸の配列表
    誰が代理人として行為できるか?
    Patent attorneys and patent agents registered to practice before the Office.
    A list of registered patent attorneys and agents may be obtained on the Internet at:
    https://oedci.uspto.gov/OEDCI/
    国内官庁は優先権の回復請求を認めるか(PCT規則49の3.2)?
    認める。国内官庁は当該請求に「故意ではない」の基準を適用する。

    国内段階の手続

    US.01 出願人
    35 USC 116,
    35 USC 117,
    35 USC 118,
    37 CFR 1.42,
    37 CFR 1.43,
    37 CFR 1.45,
    37 CFR 1.46,
    37 CFR 1.421,
    37 CFR 1.422,
    37 CFR 1.423,
    37 CFR 1.424

    For US national phase applications having an international filing date on or after 16 September 2012, the applicant may be:
    (a) the inventor(s);
    (b) the legal representative of a deceased or legally incapacitated inventor;
    (c) the assignee;
    (d) the obligated assignee (i.e., a person to whom the inventor is under an obligation to assign the invention); or
    (e) a person who otherwise shows proprietary interest in the application.
    For such applications, the person identified in the international stage as the applicant will normally be considered the applicant for the US national phase application, even if such applicant is not the inventor.
    US.02
    Where the applicant is a person who otherwise shows sufficient proprietary interest in the matter, such applicant must submit a petition including: the applicable fee, a showing that such person has sufficient proprietary interest in the matter, and a statement that making the application for patent by a person who otherwise shows sufficient proprietary interest in the matter on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties.
    US.03 発明者
    For US national phase applications with an international filing date prior to 16 September 2012, the inventor(s) is required to be the applicant(s) or, if an inventor is dead, insane, or otherwise legally incapacitated, such inventor’s legal representative. This is true even if the national phase documents are filed after 16 September 2012.
    US.04
    37 CFR 1.41
    The inventorship of a US national phase application having an international filing date on or after 16 September 2012 is the inventor or joint inventors set forth in an application data sheet accompanying the initial national phase submission (refer to paragraph US.06). If the initial national phase submission for an application with an international filing date on or after 16 September 2012 is not accompanied by a proper application data sheet, OR if the national phase application has an international filing date prior to 16 September 2012, the inventorship is the inventor or joint inventors set forth in the international application, which includes any change effected under PCT Rule 92bis.
    US.05 国内段階へ移行するための様式
    The USPTO has available a special transmittal form, Form PTO-1390 (refer to Annex US.III), to accompany the fees and documents required for entering the national phase. Use of the Form PTO-1390 is strongly encouraged because the form clearly identifies the submission as a national phase entry filed under 35 USC 371, as required for proper processing (refer to paragraph US.11). In addition, the Form PTO-1390 provides applicants with a checklist of items generally required or potentially applicable to a national phase filing, as well as a mechanism to make specific requests that may be appropriate in a particular national phase application. For example, the Form PTO-1390 contains checkboxes to expressly request that national examination procedures begin immediately (refer to paragraph US.37), to instruct the USPTO not to enter amendments made in the international phase, and to assert small entity status (refer to paragraph US.20). Use of the Form PTO-1390 is not, however, required.
    US.06 出願データ用紙(ADS)
    37 CFR 1.76,
    37 CFR 1.495(c)

    Together with the Form PTO-1390 discussed above, applicants are also strongly encouraged to submit an “application data sheet” (ADS). The ADS facilitates electronic capture of the bibliographic data by the USPTO, thus leading to more accurate data recording and quicker processing by eliminating the need to have this data manually extracted from the application documents. An application data sheet form for use where the international filing date is on or after 16 September 2012 (Form PTO/AIA/14) and instructions for preparing the form can be found at: http://www.uspto.gov/patents/apply/forms
    The Form PTO/AIA/14 is attached as Annex US.IV.
    The Form PTO/AIA/14 is attached as Annex US.IV and the Form PTO/SB/14 is attached as Annex US.V.
    US.07
    In an application with an international filing date on or after 16 September 2012, an application data sheet is required to postpone submission of the required oath or declaration of the inventors (refer to paragraph US.26, below).
    US.08 通 信
    37 CFR 1.1,
    37 CFR 1.5,
    37 CFR 1.6(d),
    37 CFR 1.6(g),
    37 CFR 1.8(a)(2)

    It is preferable to file the required national phase items online using the USPTO’s Patent Electronic System, which currently comprises EFS-Web and Patent Center. The Patent Electronic System provides customers the ability to electronically file a variety of patent application documents directly to the USPTO, including those associated with US national phase entries under 35 USC 371. It is recommended that applicants continue to use the Form PTO-1390 when electronically filing documents for entry into the US national phase under 35 USC 371 (refer to paragraph US.05). More information regarding the electronic filing of US patent applications using the Patent Electronic System may be obtained at https://www.uspto.gov/patents/apply. Full technical support is available through the Patent Electronic Business Center (EBC) at (1-866) 217 91 97 from 6 a.m. to 12 Midnight Eastern Time, Monday – Friday (except federal holidays). EBC may be emailed anytime at ebc@uspto.gov. In the event that the Patent Electronic System is not available due to an outage, information regarding alternative filing methods may be obtained at https://www.uspto.gov/patents/apply/filing-online/filing-documents-during-outage.
    US.09
    Patent Center, which will replace EFS-Web, has the added capability of enabling the electronic filing of a sequence listing in Extensible Markup Language (XML) format. This capability is important in view of the implementation of WIPO Standard ST.26, incorporated into U.S. sequence rules 37 CFR 1.831 - 1.839, which require that a sequence listing filed in any national phase application that has an international filing date on or after 1 July 2022 be in XML format in compliance with ST.26. For all applications having an international filing date before 1 July 2022, a sequence listing may be filed as an ASCII text file (.TXT) in ST.25 format, as per 37 CFR 1.821 - 1.825, but not as an ST.26 XML file. The USPTO’s Patent Electronic System has a file size limit of 100 MB for sequence listings in text or XML format, which must be uploaded separately from other types of files. Sequence listing files that exceed 100 MB can be submitted on optical disc in accordance with 37 CFR 1.52(e) on the same day by using Priority Mail Express® from the USPS in accordance with 37 CFR 1.10, or by hand delivery. Note that it is not necessary to submit a copy of a sequence listing that is part of the description of the international application upon entry into national phase at the USPTO if the international application has been published by the International Bureau (IB); the USPTO will obtain a copy of the published international application, including the sequence listing, from the IB under PCT Article 20. The inclusion of a sequence listing as part of the description is indicated on the front page of the published international application. The Patent Electronic System has a file size limit of 25 MB per PDF file, but up to 60 documents of this size may be submitted in a single electronic package.
    US.10
    National phase documents may also be submitted by mail addressed to: Mail Stop PCT, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450, USA. If the applicant has received a “Notice of Acceptance of Application Under 35 USC 371 and 37 CFR 1.495”, the reference to “Mail Stop PCT” should be deleted. If a US application number (e.g., 18/123,456) has been assigned, it should be indicated on the documents. If a US application number has not yet been assigned, the correspondence should state the name of the applicant, the international filing date, the international application number and the title of the invention. It is important to note that a copy of the international application used to enter the national phase and/or payment of the required basic national fee may NOT be submitted by facsimile.
    US.11
    35 USC 371,
    35 USC 111,
    37 CFR 1.495(g)

    A submission to enter the US national phase under the PCT is required by the USPTO to contain a clear indication of this intention. The identification requirement is usually complied with if the Form PTO-1390 for entering the national phase is used (refer to paragraph US.05 above). The identification of the international application, in the declaration or oath of the inventor (refer to paragraph US.23), as a prior filed application for priority purposes, or otherwise, is not considered to be a sufficient indication of an intention to enter the national phase under the PCT. In accordance with 37 CFR 1.495(g), an initial application submission filed on or after 16 September 2012 that contains (e.g., in the application documents and/or the data entered in the Patent Electronic System) conflicting indications as between a new US national patent application under 35 USC 111(a) and a submission to enter the national phase under 35 USC 371 will be treated by the USPTO as a submission to enter the national phase under 35 USC 371. However, an initial application submission filed prior to 16 September 2012 that contains conflicting indications will be treated as a new US national patent application under 35 USC 111(a).
    US.12 翻訳文(遅延提出)
    35 USC 371(d),
    37 CFR 1.492(i),
    37 CFR 1.495(c),
    37 CFR 1.495(d),
    37 CFR 1.495(e)

    If the applicant pays the basic national fee and a copy of the international application is received within the applicable time limit for national phase entry, but a translation of the international application has not been furnished by the applicant or is incomplete, a notice is sent to the applicant which sets a time period for furnishing the translation. The applicant can then timely furnish the translation provided that a processing fee is paid. The amount of the processing fee is indicated in Annex US.I. The time period set in the notice will be two months from the date of the notice or 32 months from the priority date, whichever is later. The time period set in the notice may be extended as provided for in 37 CFR 1.136(a) (refer to paragraph US.43(i), below). The requirement to provide a translation of the international application encompasses the sequence listing part of the description. If an ST.25 text file that contains non-English free text is part of the international application, the applicant should submit a translated sequence listing text file in which the non-English text is replaced with the English translation, and clearly identify the submission as a translation of the sequence listing part of the description. If an ST.26 XML sequence listing that is part of the international application contains one or more language-dependent qualifiers that do not include an English value, applicant should submit a translated sequence listing in which all language-dependent qualifiers have English values, and clearly identify the submission as a translation of the sequence listing part of the description. Where amendments to the claims have been filed with the International Bureau under Article 19 and the applicant fails to furnish a translation or copy (refer to the Summary of Requirements for Entry into the National Phase) of such amendments to the claims within the time limit for national phase entry, the amendments to the claims are considered to have been cancelled. A translation of any annexes, e.g. Article 34 amendments, to the International Preliminary Examination Report must be furnished prior to the expiration of the applicable time limit under PCT Article 39(1). However, a translation of the annexes may be provided during any time period set under 37 CFR 1.495(c) to furnish a translation of the international application, the inventor’s oath or declaration, the search fee, the examination fee, and/or the application size fee. If a translation of the annexes is not timely filed, the amendments contained in the annexes will be considered to be cancelled. However, such amendments may be reintroduced at a later stage (refer to paragraph US.33).
    US.13 翻訳文(補充)
    Errors in the translation of the international application can be corrected with reference to the text of the international application as filed (refer to National Phase, paragraphs 6.002 and 6.003). If the translation furnished to the USPTO was incomplete, refer to the preceding paragraph.
    [MT] 米国第14号国民費の支払い
    35 USC 371(d),
    37 CFR 1.495(b),
    37 CFR 1.6(d)(3),
    37 CFR 1.8(a)(2)(i)(F)

    The basic national fee must be paid within the time limit for entry into the national phase (refer to PCT Article 22(1) or 39(l)a)) which is 30 months after the priority date. This time limit may not be extended. If the basic national fee is not paid within the applicable time period, the application becomes abandoned as to the United States. An authorization to charge the basic national fee to a deposit account, credit card or any other means may NOT be submitted by facsimile.
    US.15 調査手数料
    37 CFR 1.492(b)(1),
    37 CFR 1.492(b)(2),
    37 CFR 1.492(b)(3),
    37 CFR 1.492(b)(4)

    If the applicant pays the basic national fee and a copy of the international application has been received within the time limit for national phase entry, but the search fee has not been paid, a notice is sent to the applicant which sets a time period for furnishing the search fee. The applicant can then furnish the search fee provided a surcharge fee is paid. The amounts of the search fee and the surcharge are provided in Annex US.I. The period set in the notice is extendable as provided in 37 CFR 1.136(a) (refer to paragraph US.43(i)).
    US.16 審査手数料
    37 CFR 1.492(c)(1),
    37 CFR 1.492(c)(2)

    If the applicant pays the basic national fee and a copy of the international application has been received within the time limit for national phase entry, but the examination fee has not been paid, a notice is sent to the applicant which sets a time period for furnishing the examination fee. The applicant can then furnish the examination fee provided a surcharge fee is paid. The amounts of the examination fee and the surcharge are provided in Annex US.I. The period set in the notice is extendable as provided in 37 CFR 1.136(a) (refer to paragraph US.43(i)).
    [MT] 米国第17号申請サイズ料
    37 CFR 1.492(j)
    For any US national phase application or national application, where the specification and drawings exceed 100 sheets of paper, for each additional 50 sheets, or fraction thereof, an application size fee will apply. For a US national phase application, the application size fee is calculated on the basis of the number of sheets of specification and drawings in the published international application, without regard to the language of the publication. The specification includes the description, claims, and abstract. Certain other sheets typically present in the international publication are not taken into account in determining the application size fee, i.e., Article 19 amendments/statement, the international search report, and any additional bibliographic sheets (other than the cover sheet containing the abstract). The amount of the fee is in Annex US.I.
    [MT] 追加保険料
    37 CFR 1.75(c),
    37 CFR 1.492(d),
    37 CFR 1.492(e),
    37 CFR 1.492(f),
    37 CFR 1.492(g),
    37 CFR 1.121(c)

    An additional claim fee is applicable for each independent claim in excess of three, for each claim in excess of 20, and for an application that contains multiple dependent claim(s). The number of additional claims for fee purposes must be computed on the basis of the claims valid at the beginning of the national phase (that is, where amendments have been filed, the claims as amended under PCT Article 19 or PCT Rule 66.1, 66.3 and 66.4 or the claims as amended in a preliminary amendment submitted in compliance with the applicable US regulations by the applicant upon entering the national phase under PCT Article 28 or 41). Where the applicant fails to pay the correct amount of the additional claims fee, the USPTO will send a notification of fee deficiency and invite payment of the fee at the amount applicable on the date of payment. To avoid abandonment, the fee must be paid or the claims canceled by amendment prior to the expiration of the time period set for reply to any notification of fee deficiency.
    [MT] 米国第19号法令「小規模企業」「小規模企業」の手数料の軽減
    37 CFR 1.27,
    37 CFR 1.28,
    37 CFR 1.29,
    37 CFR 1.33,
    37 CFR 1.492

    Applicants having a “small entity” or “micro entity” status are entitled to a reduction of 60% or 80%, respectively, in certain fees.
    US.20
    “Small entity” status can be established by a single written assertion of entitlement to “small entity” status without use of a specialized form. “Small entity” status may also be established by checking the box provided on the application data sheet discussed in paragraph US.06 or the Form PTO-1390 for entering the national phase discussed in paragraph US.05, or by payment of the exact basic national fee for a small entity. For a US national phase application with an international filing date on or after 16 September 2012, parties who may assert “small entity” status include the applicant, a patent practitioner of record or a practitioner acting in a representative capacity, the inventor or a joint inventor (if the inventor is an applicant), or the assignee. Assertion of small entity status requires a determination of entitlement to that status. For a US national phase application with an international filing date prior to 16 September 2012, parties who may assert “small entity” status include a registered practitioner, one of the inventors, or a partial assignee (an assignee assertion of small entity status must be filed by a 37 CFR 1.33(b) party).
    US.21
    “Micro entity” status can be established under either the “gross income” or “institution of higher education” basis. Under either basis, an application must also satisfy the requirements for “small entity” status. Unlike “small entity” status, “micro entity” status cannot be established by a simple statement alleging entitlement to “micro entity” status, by checking the box provided on the application data sheet or the Form PTO-1390 for entering the national phase, or by payment of the exact basic national fee. Rather, a certification of entitlement to “micro entity” status must be submitted. The USPTO provides Forms PTO/SB/15A and PTO/SB/15B for use in certifying “micro entity” status. These forms are available on the USPTO Web site at: http://www.uspto.gov/patents/apply/forms;
    copies of the certification forms are also in Annex US.VI and US.VII. The certification of “micro entity” status must be executed by a party authorized under 37 CFR 1.33(b). It should be noted that a registered practitioner is required to sign the certification for any applicant that is a corporation or organization; an officer of an assignee corporate applicant, for example, is not authorized to sign the certificate of “micro entity” status.
    US.22 手数料(支払方法)
    37 CFR 1.23
    The manner of payment of the fees indicated in the Summary and in this Chapter is outlined in Annex US.I. A copy of a Credit Card Payment Form (Form PTO-2038) and the instructions thereto is attached as Annex US.II. It should be noted that an authorization to charge the basic national fee to a deposit account, credit card or any other means may NOT be submitted by facsimile.
    発明者の宣誓書又は宣言書
    35 USC 115,
    35 USC 371(c)(4),
    35 USC 371(d),
    37 CFR 1.497,
    37 CFR 1.495(c),
    37 CFR 1.63,
    37 CFR 1.64

    As a result of changes implemented by the America Invents Act (AIA), the requirements for the oath or declaration of the inventor depend on whether an application was filed before or after 16 September 2012. A sample of an appropriate declaration for use in applications with an international filing date on or after 16 September 2012 is provided in Annex US.VII. In addition, Box No. VIII(iv) of the PCT request form (PCT/RO/101) contains a “DECLARATION: INVENTORSHIP (only for the purposes of the designation of the United States of America).” The declaration contained in Box No. VIII(iv) of the PCT request form (PCT/RO/101) was updated in the 16 September 2012 revision of the PCT request form (PCT/RO/101) to comply with the revised US law. Accordingly, the “DECLARATION: INVENTORSHIP (only for the purposes of the designation of the United States of America)” contained in previous versions of the PCT request form (PCT/RO/101) does not comply with current US law and will not be accepted by the USPTO with respect to applications with an international filing date on or after 16 September 2012.
    US.24
    For applications with an international filing date on or after 16 September 2012, a “substitute statement” may be submitted in lieu of an oath or declaration of the inventors if the inventor is deceased, is under a legal incapacity, has refused to execute the oath or declaration, or cannot be found or reached after diligent effort (a sample “substitute statement” form is provided in Annex US.X).
    US.25
    For applications with an international filing date before 16 September 2012, if the applicant pays the basic national fee and a copy of the international application is received within the time limit for entry into the national phase, but an oath or declaration of the inventor is not furnished, a notice shall be sent to the applicant which sets a time period for furnishing the oath or declaration. The applicant can then furnish the oath or declaration provided that a surcharge is paid. The amount of the surcharge is indicated in Annex US.I. The time period set in the notice will be two months from the date of the notice or 32 months from priority date, whichever is later. The time period set in the notice is extendable as provided for in 37 CFR 1.136 (a) (refer to paragraph US.43(i)).
    US.26
    For applications with an international filing date on or after 16 September 2012, the submission of an “application data sheet” (refer to paragraph US.06) identifying each inventor and providing each inventor’s residence and mailing address will permit the applicant to postpone submission of the oath or declaration of the inventor (or substitute statement, if applicable) until the application is otherwise in condition for allowance. In such cases, the USPTO will issue a Notice Of Acceptance (Form PCT/DO/EO/903) and refer the application for publication and examination; however, the Notice Of Acceptance (Form PCT/DO/EO/903) will indicate that the oath or declaration requirement has not yet been satisfied.
    US.27 委任状
    37 CFR 1.31,
    37 CFR 1.32

    No representation of the applicant by an attorney or agent is required where the applicant is an individual or individuals; however, a juristic entity (e.g., organizational assignee) must be represented by an attorney or agent. Where an attorney or agent is to represent an applicant, a power of attorney signed by the applicant/inventor to an attorney or agent registered to practice before the USPTO is required. Sample power of attorney forms for use in an application with an international filing date on or after 16 September 2012 (Forms PTO/AIA/80, 81 and 82) are in Annexes US.IX-XI. It is highly advisable to be represented by an attorney or agent.
    [MT] 米国第28情報公開声明
    37 CFR 1.56,
    37 CFR 1.97,
    37 CFR 1.98

    The applicant must (to be prudent) file with the USPTO, not later than three months from the date of entry of the national phase, an information disclosure statement. Such statement must disclose all information of which the applicant, or any other person substantively involved with the preparation of the application or its prosecution, is aware which is material to the patentability of the invention. Such information is material to patentability when it is not cumulative to information already of record in the application, and (1) it establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or (2) it refutes, or is inconsistent with, a position the applicant takes in (i) opposing an argument of unpatentability relied upon by the Office, or (ii) asserting an argument of patentability. A prima facie case of unpatentability is established when the information compels a conclusion that a claim is unpatentable by the preponderance of evidence, burden of proof standard, giving each term in the claim its broadest reasonable construction consistent with the description, and before any consideration is given to evidence which may be submitted in an attempt to establish a contrary conclusion of patentability.
    US.29
    The information disclosure statement must include:
    (1) a listing (preferably on Forms PTO/SB/08a and 08b, refer to Annex US.XII) of patents, applications, publications or other information. US patents and US patent applications must be listed in a section separately from citations of other documents. Each page of the listing must include:
    (i) the application number of the application in which the information disclosure statement is being submitted;
    (ii) a column that provides a space, next to each document to be considered, for the examiner’s initials;
    (iii) a heading that clearly indicates that the list is an information disclosure statement;
    (2) a copy of each listed item except for US patents and US patent application publications;
    (3) for each item listed which is not in the English language, a concise explanation of its relevance.
    US.30
    Applicants may also file an information disclosure statement via the Office’s electronic filing system (EFS-Web/Patent Center) by:
    (1) entering the references’ citation information in a fillable electronic form equivalent to the revised Forms PTO/SB/08a and 08b; and
    (2) transmitting the fillable electronic form data to the Office via EFS-Web/Patent Center.
    US.31
    35 USC 371,
    37 CFR 1.97,
    37 CFR 1.98

    Note, however, that the examiner will consider the documents cited in the international search report in a PCT national phase application when the Form PCT/DO/EO/903 (which is sent to notify the applicant after he has entered the national phase of the acceptance of the international application under 35 USC 371) indicates that both the international search report and the copies of the prior art documents are present in the national phase file. In such a case, the examiner will consider the documents from the international search report and indicate by a statement in the first Office action that the information has been considered. There is no requirement that the examiner list the documents on a Notice of References Cited (Form PTO-892). In order to have these prior art documents printed on any resulting patent, the applicant must provide a separate listing (preferably on Forms PTO/SB/08a and 08b). If Form PCT/DO/EO/903 does not indicate that both the international search report and copies of the prior art documents are present in the national stage file, the applicant must follow the procedures set forth in 37 CFR 1.97 and 1.98 (concerning the filing and content of information disclosure statements), as outlined above, in order to ensure that the examiner considers the documents cited in the international search report.
    US.32
    37 CFR 1.97(e)
    A translation into English of the pertinent portions in a non-English language document must be transmitted if an existing translation is readily available to the applicant. Any additional information material to the claimed invention which becomes available after the transmittal of the statement should, within three months of its availability, be submitted by a supplemental information disclosure statement. Failure to disclose completely any pertinent information may result in any resulting US patent based on the application being unenforceable. A fee or an appropriate statement under 37 CFR 1.97(e) is required if an information disclosure statement is submitted more than three months after entry to the national stage and after a first Office action is mailed, but before a final Office action or a notice of allowance is issued. After a final Office action or a notice of allowance has been issued but before payment of the issue fee, a fee and an appropriate statement under 37 CFR 1.97(e) will be required to have an information disclosure statement considered.
    US.33 出願の補正及びその時期
    The applicant may make the following amendments, provided no new matter is introduced in the disclosure of the invention:
    35 USC 133,
    37 CFR 1.111,
    37 CFR 1.112,
    37 CFR 1.113,
    37 CFR 1.114,
    37 CFR 1.115,
    37 CFR 1.116,
    37 CFR 1.117,
    37 CFR 1.118,
    37 CFR 1.119,
    37 CFR 1.120,
    37 CFR 1.121,
    37 CFR 1.122,
    37 CFR 1.123,
    37 CFR 1.124,
    37 CFR 1.125,
    37 CFR 1.126,
    37 CFR 1.127

    (i) before the final decision of the USPTO to grant or to reject the patent, the applicant may file amendments to the description, claims and drawing(s) of his own volition or when specifically required by the examiner;
    37 CFR 1.116
    (ii) after the final decision, amendments may be made only by cancelling claims or complying with any requirement of form which has been made by the examiner, or by presenting rejected claims in better form for reconsideration on appeal.
    US.34
    37 CFR 1.121,
    37 CFR 1.125

    For the manner of making amendments and the required format, refer to the applicable US regulations, in particular 37 CFR 1.121 and 1.125. One of the requirements for effectively amending claims in a national phase application is a complete listing of all claims ever presented, including the text of all pending and withdrawn claims. The status of every claim in such listing must be indicated after its claim number by one of the following identifiers in a parenthetical expression: (Original), (Currently Amended), (Canceled), (Withdrawn), (Previously Presented), (New), and (Not Entered). All “currently amended” claims must include markings to indicate the changes made relative to the immediate prior version of the claims: underlining to indicate additions, strike-through or double brackets for deletions (refer to 37 CFR 1.121(c) for further details regarding the format of claim amendments). Applicants should note that, in an amendment to the claims filed in a national phase application, the status identifier “original” must be used for claims that had been presented on the international filing date and not modified or canceled. The status identifier “previously presented” must be used in any amendment submitted during the national phase for any claims added or modified under PCT Articles 19 or 34 in the international phase that were subsequently entered in the national phase. The status identifier “canceled” must be used in any amendment submitted during the national phase for any claims canceled under an Article 19 or 34 amendment in the international phase and subsequently entered in the national phase.
    Example 1: Original claims 1-10; Article 19/34 filed with claims 1-20 listed on the replacement sheet wherein claims 1-10 were unchanged and claims 11-20 were added; the status of the claims prior to any further amendment under 37 CFR 1.121 would be as follows: claims 1-10 as “original” and claims 11-20 as “previously presented.”
    Example 2: Original claims 1-10; Article 19/34 filed with claims 1-9 listed on the replacement sheet wherein claims 1-9 were unchanged and claim 10 was cancelled; the status of the claims prior to any further amendment under 37 CFR 1.121 would be as follows: claims 1-9 as “original” and claim 10 as “cancelled.”
    Example 3: Original claims 1-10; Article 19/34 filed with claims 1-9 listed on the replacement sheet wherein claim 1 was unchanged, claim 2 was cancelled and claims 3-10 were renumbered as claims 2-9; the status of the claims prior to any further amendment under 37 CFR 1.121 would be as follows: claim 1 as “original, ”, claims 2-9 as “previously presented” and claim 10 as “cancelled.”
    Example 4: Original claims 1-10; Article 19/34 filed with claims 1-10 listed on the replacement sheet wherein claims 1 and 3-10 were unchanged and claim 2 was cancelled; the status of the claims prior to any further amendment under 37 CFR 1.121 would be as follows: claims 1 and 3-10 as “original” and claim 2 as “cancelled.”
    Proposed amendments that are not submitted in compliance with the applicable regulations will not be entered. For example, the submission with the national phase documents of a revised set of claims, absent a preliminary amendment to the claims in compliance with 37 CFR 1.121(c), will not be effective to amend the claims of record in the application.
    US.35 付与手数料
    37 CFR 1.18
    A patent issue fee and any required publication fee must be paid within a nonextendable period of three months after the mailing of a written notice of allowance. The amount of the said fee is indicated in Annex US.I.
    US.36 特許維持手数料
    37 CFR 1.20
    After a patent has been issued, a fee must be paid for maintaining the patent in force beyond four years after grant. The first such fee is due by three years and six months after issue of the patent. Where the applicant fails to pay within that time limit, he may receive an invitation to pay from the USPTO. Lack of receipt of such an invitation will not be accepted as an excuse for non-payment of the maintenance fee. Payment can then still be made together with a surcharge within the six months following the due date. The amount of the maintenance fees, of the surcharge, and their due dates are indicated in Annex US.I.
    [MT] 米国特許庁に提出前に,米国特許第37号の全国的な発明の早期開始
    35 USC 371(f)

    If the applicant desires the examination by the USPTO of his application to start earlier than the expiration of the time limit for entry into the national phase, he must file in writing an express request therefor and submit the basic national fee, a copy of the international application, a translation of the international application (if required) and an oath or declaration of the inventor. The express request may be accomplished, for example, by checking the appropriate box on the Form PTO-1390 for entry into the national phase referred to in paragraph US.05 and reproduced in Annex US.III.
    US.38
    The mechanism for deferring submission of the oath or declaration of the inventor by filing an “application data sheet” (refer to paragraph US.26) is not applicable where the applicant requests early examination by the USPTO. Such early examination of the application requires submission of the oath or declaration (or the substitute statement, if applicable).
    US.39 継続,一部継続又は分割
    35 USC 111,
    35 USC 120,
    35 USC 365(c),
    35 USC 371(c),
    37 CFR 1.76,
    37 CFR 1.78,
    37 CFR 1.495(h)

    The applicant may—instead of entering the national phase—file a continuation, continuation-in-part or divisional of the international application (hereinafter referred to as “the continuing application”), provided the international application designates the US and is not (considered) withdrawn or abandoned at the time of filing the continuing application. An international application is considered abandoned after the expiration of the time limit for entry into the national phase, which is 30 months after the priority date, if a copy of the international application and the basic national fee have not been received in the USPTO. When the basic national fee has been paid and a copy of the international application has been communicated by the International Bureau within the time limit for entry into the national phase, but additional national phase requirements have not been submitted (e.g., an English translation and/or additional required fees), a notice will be sent to the applicant to furnish such additional required materials. If the applicant does not properly respond to the notice within the time period set by the USPTO, the international application will become abandoned.
    US.40
    Basically, the normal procedure for filing continuing applications applies. The applicant must submit an application data sheet (refer to paragraph US.06) claiming the benefit of the international filing date of the international application designating the US. The reference to the international application in the application data sheet must identify the international application by international application number and international filing date, and it must indicate the relationship of the applications (i.e., continuation, continuation-in-part, or divisional). This reference to the international application must be submitted during the pendency of the continuing application, and within the later of four months from the actual filing date of the continuing application or sixteen months from the filing date of the international application. This time limit is not extendable. The USPTO may require the filing of a certified copy of the international application together with a translation thereof into English where it was filed in another language. The continuing application may be filed in a language other than English, provided a translation into English is furnished together with a surcharge (refer to Annex US.I) within the time period fixed by the USPTO in an invitation. Where, at the time of filing the continuing application, the basic filing fee has not been paid or the oath or declaration of the inventor has not been furnished, the requirement may still be complied with against payment of a surcharge within the time period fixed by the USPTO in an invitation. Use of the Form PTO-1390 reproduced in Annex US.III is not appropriate for the filing of a continuing application.
    US.41 PCT第25条の規定に基づく検査
    PCT 規則51,
    35 USC 367,
    37 CFR 1.182

    The applicable procedure is outlined in paragraphs 6.018 to 6.021 of the National Phase. If, upon review under PCT Article 25, the USPTO finds no error or omission on the part of the receiving Office or the International Bureau, a petition may be taken to the Commissioner of the USPTO, which must contain a statement of the facts involved and the point or points to be reviewed and the action requested. The fee for petition indicated in Annex US.I must be paid at the same time. Any such petition not filed within two months from the action complained of may be dismissed as untimely.
    US.42 期間を遵守しなかったことによる延滞についての許容
    PCT 規則82の2,
    37 CFR 1.137

    An application abandoned for failure to comply with a time limit during the international phase or for failure to prosecute within a statutory time period before the USPTO, may be revived as a pending application if it is shown to the satisfaction of the USPTO that the delay was unintentional. Any petition to revive an abandoned application must be filed in writing and be accompanied by a petition fee, the amount of which is indicated in Annex US.I, by a proper response to the failed action unless such response has been previously submitted and by a statement indicating that the entire delay was unintentional. The USPTO has provided Form PTO/SB/64PCT (refer to Annex US.XVI) for use as a petition to revive an unintentionally abandoned international application (use of the form is optional).
    US.43
    The US rules provide for two distinct procedures to extend the period for action or response in particular situations (the procedure which is available for use in a particular situation will depend upon the circumstances):
    37 CFR 1.136
    (i) 37 CFR 1.136(a) permits an applicant, against payment of an extension fee (refer to Annex US.I), to file a petition for extension of time up to five months after the end of the time period set to take action except
    (1) where excluded,
    (2) in interference proceedings,
    (3) where the applicant has been notified otherwise in an Office action or
    (4) where no further time is available under a set statutory period.
    The petition and fee can be filed prior to or with or after the response, but the fee must be paid within the time extended. The filing of the petition and fee will extend the time period to take action up to five months dependent on the amount of the fee paid except in those circumstances noted above. The time limit to furnish the basic national fee and a copy of the international application under 37 CFR 1.495 may not be extended.
    (ii) After entry into the national phase, 37 CFR 1.136(b) provides for petitions for extensions of time of shortened statutory or non-statutory time periods upon a showing of sufficient cause when the procedure of 37 CFR 1.136(a) is not available and if additional time is still available under a shortened statutory period or if no statutory period applies.
    Although the petition and fee procedure of 37 CFR 1.136(a) will normally be available within five months after a set period for response has expired, an extension request for cause under 37 CFR 1.136(b) must be filed during the set period for response. The amount of the petition fee is indicated in Annex US.I.
    US.44 譲渡書類の登録
    37 CFR 3.21,
    37 CFR 3.24,
    37 CFR 3.28,
    37 CFR 3.31

    The USPTO will record assignments relating to international patent applications which designate the US. The assignment must identify the application by the international application number. Each document submitted for recording must be accompanied by a cover sheet referring to the international application. A sample recordation form cover sheet is contained in Annex US.XV. Each cover sheet must contain:
    1) the name of the party conveying the interest;
    2) the name and address of the party receiving the interest;
    3) a description of the interest conveyed or transaction to be recorded;
    4) the application number;
    5) the name and address of the party to whom correspondence concerning the request to record the document should be mailed;
    6) the number of applications, patents or registrations identified in the cover sheet and the total fee;
    7) the date the document was executed;
    8) a statement by the party submitting the document that to the best of the person’s knowledge and belief, the information contained on the cover sheet is true and correct and any copy submitted is a true copy of the original document; and
    9) the signature of the party submitting the document.
    US.45
    Assignments may be filed electronically via the Electronic Patent Assignment System (EPAS). EPAS may be accessed directly at the following web address: https://epas.uspto.gov. General information about the electronic filing of assignments may be obtained from the Assignment Services Division Customer Service Desk at (1-571) 272-3350 during regular business hours or via e-mail directed to EPAS@uspto.gov. Applicants should note that assignments may NOT be filed via the EFS-Web/Patent Center electronic filing system.
    US.46 出願公開
    37 CFR 1.211,
    37 CFR 1.213,
    37 CFR 1.221

    Each international application in compliance with 35 USC 371 and continuing application (refer to paragraph US.39) from an international application will be published promptly after the expiration of eighteen months from the earliest filing date for which a benefit is sought, unless the application (1) is no longer pending; (2) is subject to national security provisions; (3) has issued as a patent; or (4) was filed with a nonpublication request in compliance with 37 CFR 1.213(a). (A nonpublication request may not be filed if the international application designated any States in addition to or other than the United States of America.) The publication fee (refer to Annex US.I) must be paid before the patent will be granted. If the application is not published under this section, the publication fee (if paid) will be refunded.
    US.47 仮特許権
    35 USC 154(d),
    37 CFR 1.417

    35 USC 154(d) provides for provisional rights based on international applications. A patent will include the right to obtain a reasonable royalty from any person who partakes of any of the actions listed in 35 USC 154(d)(1) during the period commencing on the date of the publication under PCT Article 21(2)(a) of the international application designating the US, if the publication is in English, or if the publication is in a language other than English, on the date the USPTO receives a translation of the publication in the English language, and ending on the date the patent is issued. The submission of the international publication or an English language translation of the international application pursuant to 35 USC 154(d)(4) must clearly identify the international application to which it pertains (37 CFR 1.5(a)) and, unless it is being submitted pursuant to 37 CFR 1.495, be clearly identified as a submission pursuant to 35 USC 154(d)(4). Otherwise, the submission will be treated as a filing under 35 USC 111(a). Such submissions should be marked “Mail Stop PCT.” The right to obtain a reasonable royalty is not available unless the invention as claimed in the patent is substantially identical to the invention claimed in the published international application.
    US.48 様 式
    All forms are available online at:
    http://www.uspto.gov/patents/apply/forms

    附属書

    付属書 US.I-手数料
    The amounts of these fees change periodically. The United States Patent and Trademark Office or the current USPTO Fee Schedule should be consulted for the applicable amounts at:
    https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
    国内手数料
    A national fee calculation sheet appears in Annex US.III
    基本国内手数料(37 CFR 1.492(a))
    320 USD
    小企業 (USD 128) 11
    極小企業 (USD 64) 12
    [MT] 検索料(37 CFR 1.492(b)):
    国際予備審査機関(US)が特許性に関する国際予備報告(第Ⅱ章)を作成する,又は国際調査機関(US)が書面による見解を作成した場合であって,提出されたすべての請求の範囲がPCT第33条(1)から(4)までの規定を満たしている場合
    0 USD
    小企業(無料) 11
    極小企業(無料) 12
    [MT] ISAとしてUSPTOに支払われる国際検索料
    140 USD
    Small entity (56 USD) 11
    Micro entity (28 USD) 12
    国以外の国際調査機関が調査報告書を作成した場合であって,調査報告が提出される又は国際事務局から既にUSPTOに送達されている場合
    540 USD
    小企業 (USD 216) 11
    極小企業 (USD 108) 12
    その他の状況すべて
    700 USD
    小企業 (USD 280) 11
    極小企業 (USD 140) 12
    審査手数料(37 CFR 1.492(c)):
    国際予備審査機関(US)が特許性に関する国際予備報告(第Ⅱ章)を作成する,又は国際調査機関(US)が書面による見解を作成した場合であって,提出されたすべての請求の範囲がPCT第33条(1)から(4)までの規定を満たしている場合
    0 USD
    小企業(無料) 11
    極小企業(無料) 12
    その他の状況すべて
    800 USD
    小企業 (USD 320) 11
    極小企業 (USD 160) 12
    100枚を超える明細書及び図面,50枚又はその端数ごと(電子媒体で提出された配列リスト又はコンピュータプログラムを除く)(37 CFR 1.492(j))
    420 USD
    小企業 (USD 168) 11
    極小企業 (USD 84) 12
    [MT] 独立した請求権が3つ以上ある場合は,それぞれの独立請求権が3つを超えるときは,追加請求権料(37CFR1.492(d))
    480 USD
    小企業 (USD 192) 11
    極小企業 (USD 96) 12
    [MT] 追加請求料は,独立又は依存形式の請求が20件以上ある場合,20件を超える請求につき1件(37CFR1.492(e))
    100 USD
    小企業 (USD 40) 11
    極小企業 (USD 20) 12
    [MT] 申請書に複数の依存クレームが含まれている場合,申請当たりの複数依存クレーム料(37CFR1.492(f))
    860 USD
    小企業 (USD 344) 11
    極小企業 (USD 172) 12
    [MT] 請求権料の計算においては,複数の依存請求権は,それが依存する請求権の数と同じ数の独立請求権と同様に扱うべきであり,複数の依存請求権に依存する請求権についても同様である(例えば,3つの請求権に依存する請求権は,3つの依存請求権の請求権料を要する)。
    国内段階手続の開始日後の,調査手数料若しくは審査手数料の支払,又は誓約書若しくは宣言書の提出のための割増料(37 CFR 1.492(h))
    160 USD
    小企業 (USD 64) 11
    極小企業 (USD 32) 12
    [MT] PCT第22条又は第39条第1項に適用される期限を過ぎた国際申請の英訳申請の処理費(37CFR1.492(i))
    140 USD
    Small entity (56 USD) 11
    Micro entity (28 USD) 12
    国内手数料の減額
    Reductions of the national fee are indicated under the national fees listed above.
    その他の手数料
    公開手数料(37 CFR 1.18(d)(1))
    0 USD
    小企業(無料) 11
    極小企業(無料) 12
    再公開の公開手数料(37 CFR 1.18(d)(3))
    320 USD
    小企業 (USD 320) 11
    極小企業 USD 320 12
    実用特許証の発行手数料(37 CFR 1.18(a)(1))
    1,200 USD
    小企業 (USD 480) 11
    極小企業 (USD 240) 12
    [MT] 再発行手数料(37CFR1.18(a)(1))
    1,200 USD
    小企業 (USD 480) 11
    極小企業 (USD 240) 12
    維持手数料
    Maintenance fees are payable for international applications filed on or after 12 December 1980. Check the current USPTO Fee Schedule for current amounts of the maintenance fees at the time payment is due at:
    https://www.uspto.gov/learning-and-resources/fees-and-payment/uspto-fee-schedule
    [MT] 特許の有効期間を4年以上とするため(特許の授与から3年6か月以内に有効となる)(37CFR1.20(e))
    2,000 USD
    小企業 USD 800 11
    極小企業 USD 400 12
    [MT] 特許権の有効期間を8年以上とする場合(特許権の授与から7年6か月経過後)(37 CFR 1.20(f))
    3,760 USD
    小企業 USD 1,504 11
    極小企業 USD 752 12
    [MT] 特許の有効期間を12年以上とするため(特許発給後11年6か月以内に有効)(37CFR1.20(g))
    7,700 USD
    小企業 USD 3,080 11
    極小企業 USD 1,540 12
    [MT] メガシーケンスリスト出願料:
    - 300MBから800MBまでの配列リスト提出(37 CFR 1.21(o)(1))
    1,060 USD
    小企業 (USD 424) 11
    極小企業 (USD 212) 12
    - 800MBを超える配列リスト提出(37 CFR 1.21(o)(2))
    10,500 USD
    小企業 (USD 4,200) 11
    極小企業 (USD 2,100) 12
    [MT] 特許申請手続き費
    37 CFR 1.136(a)の規定による応答延長手数料
    [MT] -最初の月以内に(37 CFR 1.17(a)(1))
    220 USD
    小企業 (USD 88) 11
    極小企業 (USD 44) 12
    - 第2箇月以内(37 CFR 1.17(a)(2))
    640 USD
    小企業 USD 256 11
    極小企業 USD 128 12
    [MT] 第三か月以内に
    1,480 USD
    小企業 USD 592 11
    極小企業 USD 296 12
    - 第4箇月以内(37 CFR 1.17(a)(4))
    2,320 USD
    小企業 USD 928 11
    極小企業 USD 464 12
    - 第5箇月以内(37 CFR 1.17(a)(5))
    3,160 USD
    小企業 USD 1,264 11
    極小企業 USD 632 12
    37 CFR 1.97(c)及び(d)の規定による情報開示説明書の送付(37 CFR 1.17(p))
    260 USD
    小企業 USD 104 11
    極小企業 USD 52 12
    長官に対する申請
    [MT] 請願料:
    [MT] 37 CFR 1.55(c)(37 CFR 1.17(m))に基づく先行外国申請の優先権の復活
    2,100 USD
    小企業(USD 840) 11
    極小企業(USD 420) 12
    [MT] 外国先発明の優先権を主張する場合,その主張が意図的に遅延した場合,その主張を受理するための手続きについて,第37章第155条(e)項(第37章第117条(m)項)に基づき,次のような規定を定めた。
    2,100 USD
    小企業(USD 840) 11
    極小企業(USD 420) 12
    [MT] 外国優先申請の認証書の受理に関する規定(第37章第155条第f項(第37章第117条第g項))
    220 USD
    小企業 (USD 88) 11
    極小企業 (USD 44) 12
    [MT] 米国特許法第37条1項78項b項(第37条1項17項m項)に基づく先発明の優先権の回復
    2,100 USD
    小企業(USD 840) 11
    極小企業(USD 420) 12
    [MT] 37 CFR 1.78(c)(37 CFR 1.17(m))に基づく米国臨時申請の利益に対する意図せず遅延した請求の受理に関する
    2,100 USD
    小企業(USD 840) 11
    極小企業(USD 420) 12
    [MT] 37CFR1.78(e)(37CFR1.17(m))に基づく先行米国非暫定申請又は国際申請の利益に対する意図せず遅延した請求の受理に関する
    2,100 USD
    小企業(USD 840) 11
    極小企業(USD 420) 12
    [MT] 37 CFR 1. 137(a) の下で 意図的に放棄された申請の復活に対して
    2,100 USD
    小企業(USD 840) 11
    極小企業(USD 420) 12
    [MT] 特に規定されていない事項についての決定については
    420 USD
    小企業 (USD 168) 11
    極小企業 (USD 84) 12
    手数料の支払方法
    All payments must be made in US dollars
    支払は次のいずれかの方法が認められる
    ― 米国郵便為替(37 CFR 1.23)
    ― 小切手(37 CFR 1.23)
    ― USPTO預金口座(37 CFR 1.25)
    ― クレジットカード(37 CFR 1.23(b))
    郵便為替及び小切手での支払は米国・ドル建で「Director of the U.S. Patent and Trademark Office」宛に行う。外国からの送金は,所定の手数料全額を支払い,米国ですみやかに換金可能なものとする必要がある。すべての支払には,完全な出願番号,出願人の氏名又は名称,支払手数料の種類を表示する。
    Payment for all fees may be made using one of the following credit cards: MasterCard, VISA, American Express and Discover. Payment using a debit card or check card will not be accepted. Applicants making payments by credit card should use form PTO-2038 contained in this Annex. Blanket authorizations of payments to credit cards will not be accepted. The fee amount must be specified. Credit card authorization may be used only one time. Subsequent charges will require a new authorization. ADVISORY: If filing by EFS-Web/Patent Center, do NOT attach the PTO-2038 form as a PDF along with your EFS-Web/Patent Center submission. Please be advised that this is not recommended and by doing so your credit card information may be displayed via PAIR. To protect your information, it is recommended paying fees online by using the electronic payment method. The PTO-2038 should only be mailed or faxed to the USPTO. The PTO-2038 may not be faxed to the USPTO when paying the basic national fee.
    For information concerning electronic transfer of funds to the USPTO, please contact Jusu Jallah, Office of Finance at:
    (571) 272-7473 or (571) 272-6500
    fax (571) 273-7473
    Applicants choosing to pay by electronic transfer should insure that the full amount of the fee due is received by the USPTO. There is a danger of loss of rights if bank charges are deducted
    Additional information regarding acceptable methods for paying fees to the USPTO can be found at:
    https://www.uspto.gov/learning-and-resources/fees-and-payment/accepted-payment-methods
    Notes:
    1 a This Office has limited its availability as International Searching Authority to 250 international applications per quarter. For further details, refer to https://www.uspto.gov/web/offices/com/sol/og/2014/week52/TOC.htm#ref20
    2 a This Authority is competent only where it has not received more than 100 international applications from the USPTO during the relevant fiscal quarter. For further information, refer to http://www.uspto.gov/sites/default/files/documents/mod-ilpo-isa-ipea.pdf
    3 a This Authority is competent only if it has not received more than 8,400 international applications from the USPTO during the five year period from 1 July 2018 to 30 June 2023, not more than 300 applications per quarter during the first and second years, and not more than 500 applications per quarter during the third, fourth and fifth years.
    4 a b c d e This Authority is competent only if the international search is or has been carried out by that Office.
    5 a b c d e f g h i j k l m This amount is applicable in case of filing by a “small entity”. For further details on the entitlement to and the establishment of “small entity” status, refer to http://www.uspto.gov/web/offices/pac/mpep/s509.html#d0e30961 and 37 CFR 1.27 at: http://www.uspto.gov/web/offices/pac/mpep/consolidated_rules.pdf.
    6 a b c d e f g h i j k l m This amount is applicable in case of filing by a “micro entity”. For further details on the entitlement to and the establishment of “micro entity” status, refer to http://www.uspto.gov/web/offices/pac/mpep/s509.html#ch500_d1ff69_210b3_1ca and 37 CFR 1.29 at: http://www.uspto.gov/web/offices/pac/mpep/consolidated_rules.pdf.
    7 a b c d e f g h i j k l m n o The amount in parentheses is applicable in case of filing by a “small entity” (refer to paragraphs US. 19-21).
    8 a b c d e f g h i j k l m n o The amount in parentheses is applicable in case of filing by a “micro entity” (refer to paragraphs US. 19-21).
    9 a Refer to paragraphs US 23-26.
    10 a Should be filed within three months from performing the acts for entering the national phase (refer to 37 CFR 1.491).
    11 a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  €  ‚ ƒ „ The amount in parentheses is applicable in case of filing by a “small entity.” “Small entity” status can be established by a simple written assertion of entitlement to “small entity” status, or by payment of the exact amount of the “small entity” basic national fee as set forth in 37 CFR 1.492(a) (refer to 37 CFR 1.27, paragraph US.14 and Annex US.VI).
    12 a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  €  ‚ ƒ „ The amount in parentheses is applicable in case of filing by a “micro entity”. For further details on the establishment of “micro entity” status, refer to page 75033 at: http://www.uspto.gov/aia_implementation/77fr75019.pdf.
    Historical version applicable from 25 1月 2024 , printed on 6 12月 2025